People · Operator
Named in public records as an officer, director or promoter · active 2021–2024 · Other, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Liminal Insights, Inc. | — | Other | Series B | $38.9M | $62.8M | 2024 |
| Ls Biopath, Inc. | — | Biotechnology | Series A | $8.7M | $156.9M | 2021 |
Rusmin Kudinar at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rusmin Kudinar on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Maureen Boyce | 1 | 3 |
| Alfred Lam | 1 | 3 |
| Keisuke Ide | 1 | 2 |
| Laura Oliphant | 1 | 2 |
| Minhye Mueller | 1 | 1 |
| AMIR LEV | 1 | 1 |
| Jim Pfeiffer | 1 | 1 |
| MOSHE SARFATY | 1 | 1 |
| Mira Inbar | 1 | 1 |
| Andrew Hsieh | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.